Tag:

NeuroSearch

Latest Headlines

Latest Headlines

NeuroSearch investors thrill to trial data

Shares of NeuroSearch surged on the news that its obesity drug tesofensine produced very good data in a Phase IIb trial. The drug hit all endpoints with a high statistical significance. One analyst